Nicolle, L. E.

patient mupirocin carriage staphylococcus aureus haemodialysi infection haemodialysis patients therapy study post-therapy staphylococcus aureus aweus infections culture month mupirocin-resistant staphylococcus aureus relapse hemodialysi staphylococcus aweus 3 months 22 patients staphylococcus aureus infections haemodialysis unit phage types phage post-therapy phage types hemodialysis patients trial resistance ointment holton study nurse 17 patients recolonized population failure 3.8 weeks efficacy hygiene colonization canada subject laboratory treatment 2 months disease control haemodialysis patients.r 7 disease rna isoleucyl-transfer correspondence randomized placebo-controlled trial oxacillin chemother dr shirley parker incidence ese 10 infections surveillance fistula site infections 14 patients recolonized bacitracin 1 month dialysis gram-positive skin pathogens haemodialysis patients 135 mueller hinton plates strain bacitracin control 4. yu vl patient populations 6a ~ uy ~uscarriers 4 weeks post-therapy staphylococcus aureus colonization lancet blood agar plate carrier antimicrob methicillinresistant staphylococcus aureus staphylococcus aureus cellulitis paraffin /lanolin base amies transport media aureu ~ carriage